SCHEMBL29958380

SCHEMBL29958380

NC(=O)C=C1c2ccccc2Oc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 3/20 0.43
▸ TOP1 P11387 1/20 0.41
▸ TOP2A P11388 1/20 0.41
▸ P2RX4 Q99571 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ MCL1 Q07820 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HDAC3 O15379 3/20 0.37
▸ HDAC1 Q13547 3/20 0.37
▸ HDAC2 Q92769 3/20 0.37
▸ HDAC4 P56524 2/20 0.37
▸ HDAC7 Q8WUI4 2/20 0.37
▸ HDAC10 Q969S8 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28899441 1.00 ATM (0.43) ATMTOP1TOP2AP2RX4CYP1A2
SCHEMBL2749071 0.82 TOP1 (0.42) ATMTOP1TOP2AP2RX4MEN1
SCHEMBL4928476 0.81 HDAC3 (0.39) CYP1A2CYP2D6MEN1ALDH1A1KMT2A
SCHEMBL9421176 0.69 TOP1 (0.41) ATMTOP1TOP2AP2RX4CYP1A2
SCHEMBL8215227 0.69 KEAP1 (0.49) ATMP2RX4CYP1A2CYP2D6ALDH1A1
SCHEMBL4522727 0.69 MAPK1 (0.43) ATMTOP1TOP2ACYP1A2CYP2D6
SCHEMBL10005481 0.69 MAPK1 (0.43) ATMTOP1TOP2AP2RX4CYP1A2
SCHEMBL8445731 0.68 TOP1 (0.56) TOP1TOP2ACYP1A2CYP2D6MEN1
SCHEMBL14273164 0.68 TOP1 (0.56) TOP1TOP2ACYP1A2CYP2D6MEN1
Acetamide SCHEMBL28954498 0.68 ATM (0.54) ATMP2RX4MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624214-B2 Polymerizable absorbers of UV and high energy visible light JOHNSON & JOHNSON VISION CARE, INC. (US) 2026-05-12 — — US disclosed
US-12595370-B2 Polymerizable absorbers of UV and high energy visible light JOHNSON & JOHNSON VISION CARE, INC. (US) 2026-04-07 — — US disclosed
US-20240067825-A1 POLYMERIZABLE ABSORBERS OF UV AND HIGH ENERGY VISIBLE LIGHT JOHNSON & JOHNSON VISION CARE (US) 2024-02-29 — — US disclosed
US-20220340760-A1 POLYMERIZABLE ABSORBERS OF UV AND HIGH ENERGY VISIBLE LIGHT JOHNSON & JOHNSON VISION CARE, INC. 2022-10-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595370-B2 Polymerizable absorbers of UV and high energy visible light NLRP3, NLRP1, XDH ATM 31/4885TOP1 1054/4885TOP2A 837/4885
US-12624214-B2 Polymerizable absorbers of UV and high energy visible light CRY1, SCNN1G, MALT1 ATM 270/4885TOP1 660/4885TOP2A 1209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback